Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Narayanan

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics. Part A|September 29, 2020
Phenotypic diversity and genetic complexity of PAX3-related Waardenburg syndromePuneeth H Somashekar, Priyanka Upadhyai, Dhanya L Narayanan, et al.
Cancer Treatment Reports|May 1, 1986
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in miceJ Plowman, V L Narayanan, D Dykes, et al.
Environmental and Molecular Mutagenesis|January 1, 1996
Tissue specificity of spontaneous point mutations in lambda supF transgenic miceE G Leach, L Narayanan, P A Havre, et al.
Biochemical and Biophysical Research Communications|November 15, 1988
Reaction products of a new anti-cancer agent, Pt(IV)(cyclohexyldiamine)Cl4, with guanosine and 9-methylguanine: first crystal structures of Pt(cyclohexyldiamine) complexes with a nucleobase and a nucleosideH K Choi, A Terzis, R C Stevens, et al.
Cancer Research|February 15, 1995
Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in miceJ Plowman, D J Dykes, V L Narayanan, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitroP A Svingen, A Tefferi, T J Kottke, et al.
Journal of Medicinal Chemistry|April 1, 1989
Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activityH M Deutsch, J A Glinski, M Hernandez, et al.
Journal of Medicinal Chemistry|September 1, 1978
Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanolsM E Condon, C M Cimarusti, R Fox, et al.
Journal of Medicinal Chemistry|September 15, 1995
Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl aminesW K Anderson, R Kasliwal, D M Houston, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics. Part A|September 29, 2020
Phenotypic diversity and genetic complexity of PAX3-related Waardenburg syndromePuneeth H Somashekar, Priyanka Upadhyai, Dhanya L Narayanan, et al.
Cancer Treatment Reports|May 1, 1986
Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in miceJ Plowman, V L Narayanan, D Dykes, et al.
Environmental and Molecular Mutagenesis|January 1, 1996
Tissue specificity of spontaneous point mutations in lambda supF transgenic miceE G Leach, L Narayanan, P A Havre, et al.
Biochemical and Biophysical Research Communications|November 15, 1988
Reaction products of a new anti-cancer agent, Pt(IV)(cyclohexyldiamine)Cl4, with guanosine and 9-methylguanine: first crystal structures of Pt(cyclohexyldiamine) complexes with a nucleobase and a nucleosideH K Choi, A Terzis, R C Stevens, et al.
Cancer Research|February 15, 1995
Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in miceJ Plowman, D J Dykes, V L Narayanan, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitroP A Svingen, A Tefferi, T J Kottke, et al.
Journal of Medicinal Chemistry|April 1, 1989
Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activityH M Deutsch, J A Glinski, M Hernandez, et al.
Journal of Medicinal Chemistry|September 1, 1978
Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanolsM E Condon, C M Cimarusti, R Fox, et al.
Journal of Medicinal Chemistry|September 15, 1995
Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl aminesW K Anderson, R Kasliwal, D M Houston, et al.
Pageof 10